Pharmtech&Ingredients 2019: 470 companies, 100 New Exhibitors and Topical Issues of the Business Programme
The Government of the Russian Federation is currently working on Pharma 2030 strategy intended to elaborate and expand the core ideas enshrined in the antecedent document — Pharma 2020. The cornerstone of the new strategy are the provisions aimed at increasing and strengthening domestic production of medicines, ensuring research & technology advancement and socially-oriented development of the industry, and increasing the life expectancy of the population. Pharma 2030 provides for implementing ultra-modern technologies in the manufacture of key medicines, integrating automated systems, and boosting cooperation between production, research, and education.
In addition, the ambition is to increase the domestic output of raw materials and supplies in order to supply them to the Russian industry in sufficient quantities. Furthermore, the output is supposed to reach the levels making it possible to launch robust exports to the world market and quadruple their volumes as compared to 2017.
Pharmtech & Ingredients today is a unique exhibition project of high importance to the industry that promotes domestic production and cooperation between international innovators and Russian drug-makers.
In 2018, the exhibition celebrated its anniversary — the 20th exhibition was held with a lot of success and gathered over 440 companies from 32 countries on a total area over 18,000 sq.m. featuring a collective exposition of Indian companies that made their debut at the exhibition.
This year, the exhibition will feature over 470 major Russian and foreign companies. Over 100 companies are new exhibitors, including Japanese, Vietnamese, and Brazilian manufacturers that will make a debut with their expositions. Manufacturers and suppliers from Germany, Switzerland, India, and China will exhibit in their national pavilions. At that, the number of Chinese companies offering raw materials and ingredients for the pharmaceutical industry to the Russian market has doubled.
The companies will traditionally display innovative technologies and solutions designed to optimise the production processes.
BASF will present its scientifically grounded formulation prediction system facilitating the creation of technologically advanced medicines. The digital assistant will help reduce the complexity and cost of the medicine development process and minimise the risk of disruption.
Analitika M making its debut at the exhibition will present CELLINK technology — 3D bioprinters and bioink used with success by over 700 labs in 50 countries worldwide. They primarily stand out for their compatibility with any type of cells in any bioprinting system, high cell survival rates, unlimited software updates, and a huge database of 3D models.
TrekМark will present its drug labelling equipment in action. The company’s stand will demonstrate a full labelling cycle in real time from creation of a medicine serialisation order through completion thereof at the cash register equipment at the point of sale.
Contract manufacturing of medical products at pharmaceutical manufacturers’ facilities is a booming sector today. In order to optimise their processes, multiple companies are willing to take proactive steps to outsource the production of their medicines. The programme of the exhibition has included a section devoted to contract manufacturing since 2016. In 2019, 50 companies will present their expositions.
Traditionally, the exhibition business programme serves as a platform for a meaningful dialogue between the leading experts in the pharmaceutical industry, representatives of government regulatory agencies, and top managers of Russian and foreign companies who will discuss the most pressing problems and topical issues of the industry this year.
On 19 November, round table discussion: Total readiness for medicine labelling will be held. The event will be dedicated to the forthcoming launch of mandatory labelling of medicines with identification marks involving cryptographic protection and traceability of medicines along the entire distribution chain. The round table will cover the issues concerning serviceability of the information system for monitoring the movement of medicines, as well as the initial results of labelling and traceability of medicines included in Russia’s Seven Nosologies Programme. Association of Russian Pharmaceutical Manufacturers (ARFP) is the co-organiser of the event.
The next event on the business programme agenda is round table discussion: Export potential: new growth points organised in partnership with GMP News. The discussions will cover the most topical issues: state measures of support and targets for pharmaceutical exports, development prospects of the Eurasian Economic Union’s pharmaceutical market and integration of the union into the international trade system, operational schemes and creation of entry points to international markets based on the case studies of Russian and international companies.
On 20 November, Discussion session: An effective view on technical support for medicines production will be held. The participants will touch upon the problem of efficiency at different stages of a pharmaceutical enterprise’s life cycle and will give special attention to the innovative solutions that improve efficiency at different stages. Representatives of both process equipment manufacturers and drug-makers (BWT, Marchesini, IMA, FPT) are expected to take the floor.
Round table discussion: API production: the economic aspect will be held on the same day. The participants will discuss provision of the pharmaceutical industry with home-produced raw materials and auxiliary supplies, perforation in government procurement for the companies that have localised API facilities, and economic effect of perforation. The list of speakers includes Alexey Alekhin, Head of Department of Pharmaceutical and Medical Industry Development, Zakhar Golant, General Director, Baltpharma, Georgy Khachiyan, General Director, Reatorg LLC, Ratmir Dashkin, General Director, Mendeleev Engineering Centre, etc.
The 14th International Forum Pharmtechprom will open on 20 November. The 2-day programme of the forum includes 4 sessions featuring Russian and international experts:
· Session A: Raw materials and pharmaceutical ingredients
· Session B — Technologies and equipment for pharmaceutical production
· Session C: Packaging equipment and materials
· Session D — Auxiliary processes in pharmaceutical production
The forum will feature Alexandra Voskoboynikova, Deputy General Director for International Economic Activity, CJSC FPK PharmVILAR, Renat Kashapov, manager for pharmaceutical raw materials, Merck, Janny Hsing, CEO, Bona Pharma Packaging, Andrey Zavarzin, CEO, Greenvan LLC, and the other leading experts of pharmaceutical raw materials and equipment manufacturers.
InterPharmTechnology Group is the visitor registration area sponsor
Merck is the visitor lanyard sponsor
ERWEKA is the technological partner of the exhibition
Pharmvestnik is the general information partner
GMP News is the strategic partner